GlassScriptPhysician profile
Pedro Daniel Gonzalez
NPI 1609846682
$12,910.35
in general payments reported to CMS, 2019-2025
65 companies · $1,806 in 2025
The $1,806 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,194 · 2020: $1,429 · 2021: $1,954 · 2022: $1,784 · 2023: $2,386 · 2024: $1,358 · 2025: $1,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,435 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,435.22 |
| Education | $114.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,823.02 | 2021-2025 | |
| Glaxosmithkline, LLC. | $1,100.84 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $841.54 | 2019-2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $820.18 | 2019-2025 | Jardiance |
| Pfizer INC. | $787.85 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $670.58 | 2019-2024 | Airsupra |
| Lilly USA, LLC | $518.55 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Corium, LLC | $490.74 | 2021-2025 | Azstarys |
| Tris Pharma INC | $461.25 | 2019-2024 | Dyanavel Xr |
| Allergan, INC. | $434.73 | 2019-2020 | |
| Inspire Medical Systems, INC. | $350.07 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $331.97 | 2019-2025 | |
| Astellas Pharma US INC | $304.89 | 2019-2024 | Veozah, Myrbetriq |
| Amarin Pharma, INC. | $295.85 | 2019-2021 | |
| Corcept Therapeutics | $225.33 | 2024-2025 | Korlym |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.